Potentially inapproriate medication use among elderly home care patients in Europe

JAMA

Volumn 293, Issue 11, 2005, Pages 1348-1358

  Fialová, Daniela ^a   Topinková, Eva ^a   Gambassi, Giovanni ^b   Finne Soveri, Harriet ^c   Jonsson, Pálmi V ^d   Carpenter, Iain ^e   Schroll, Marianne ^f   Onder, Graziano ^b   Sørbye, Liv Wergeland ^g   Wagner, Cordula ^h   Reissigová, Jindra ⁱ   Bernabei, Roberto ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CATHOLIC UNIVERSITY   (Italy)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^e UNIVERSITY OF KENT   (United Kingdom)

^f BISPEBJERG HOSPITAL   (Denmark)

^g Decon College   (Norway)

^h NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

ⁱ INSTITUTE OF COMPUTER SCIENCE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMITRIPTYLINE; ANALGESIC AGENT; ANTIANEMIC AGENT; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIARRHEAL AGENT; ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANXIOLYTIC AGENT; BARBITURIC ACID DERIVATIVE; CHLORDIAZEPOXIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; DIGOXIN; DIPYRIDAMOLE; DIURETIC AGENT; DOXAZOSIN; ESTROGEN; FLUOXETINE; NEUROLEPTIC AGENT; NIFEDIPINE; OXYBUTYNIN; PENTOXIFYLLINE; PIROXICAM; TICLOPIDINE; UNINDEXED DRUG;

AGED; ARTICLE; CLINICAL PRACTICE; CZECH REPUBLIC; DENMARK; DEPRESSION; DRUG MISUSE; EDUCATION; ELDERLY CARE; EUROPE; FEMALE; FINLAND; HIGH RISK POPULATION; HOME CARE; HUMAN; ICELAND; ITALY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NORWAY; POLYPHARMACY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK MANAGEMENT; SOCIAL ISOLATION; SOCIOECONOMICS; UNITED KINGDOM; UNITED STATES; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; GERIATRICS; MEDICATION ERROR; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; EUROPE; FEMALE; GERIATRICS; HOME CARE SERVICES; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ERRORS; RETROSPECTIVE STUDIES;

EID: 20044362718     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.11.1348     Document Type: Article

References (46)

1. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001;49:200-209.
2. Cohen JS. Avoiding adverse reactions: effective lower-dose drug therapies for older patients. Geriatrics. 2000;55:54-64.
3. Hanlon JT, Artz MB, Pieper CF, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004;38:9-14.
4. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly. JAMA. 2001;286:2823-2829.
5. Gray SL, Hedrick SC, Rhinard EE, et al. Potentially inappropriate medication use in community residential care facilities. Ann Pharmacother. 2003,37: 988-993.
6. Lane ChJ, Bronskill SE, Sykora K, et al. Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc. 2004;52:861-866.
7. Goulding MR. Inappropriate medications prescribing for elderly ambulatory care patients. Arch Intern Med. 2004;164:305-312.
8. Malik AB, Bishara O. Polypharmacy: quality of care in homebase primary care setting. J Am Geriatr Soc. 2003;51(suppl):S123.
9. Balogun SA, Preston M, Evans J. Correlates of potentially inappropriate medication use among newly admitted nursing home patients. J Am Geriatr Soc. 2003;51(suppl):S103.
10. Stuck AE, Beers MH, Steiner A, et al. Inappropriate medication use in community-residing older persons. Arch Intern Med. 1994;154:2195-2200.
11. Curtis LH, Ostbye T, Sendersky V, et al. Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med. 2004;164:1621-1625.
12. Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med. 2004;116:394-401.
13. Fick DM, Waller JL, Maclean JR, et al. Potentially inappropriate medication use in a Medicare managed care population: association with higher cost and utilization. J Manag Care Pharm. 2001;7:407-413.
14. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck J. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825-1832.
15. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med. 1997;157:1531-1536.
16. McLeod PJ, Huang AR, Tamblyn RM, Cayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997; 156:385-391.
17. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003;163:2716-2724.
18. Giron MS, Wang HX, Bernsten C, Thorslund M, Winblad B, Fastbom J. The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc. 2001;49:277-283.
19. Pitkala KH, Strandberg TE, Tilvis RS. Inappropriate drug prescribing in home-dwelling elderly patients: a population/based survey. Arch Intern Med. 2002;162:1707-1712.
20. Onder G, Landi F, Cesari P, Gambassi C, Carbonin P, Bernabei R. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol. 2003;59:157-162.
21. Carpenter CI, Gambassi C, Topinková E, et al. Community Care in Europe: the Aged in Home Care project (AdHOC). Aging Clin Exp Res. 2004;16:259-269.
22. Morris JN, Fries BE, Steel K, et al. Comprehensive clinical assessment in community setting: applicability of the MDS-HC. J Am Geriatr Soc. 1997;45:1017-1024.
23. Landi F, Tua E, Onder G, et al. Minimum data set for home care: a valid instrument to assess frail older people living in the community. Med Care. 2000;38: 1184-1190.
24. Morris JN, Fries BE, Morris SA. Scaling ADL within the MDS. J Gerontol A Biol Sci Med Sci. 1999;54: M546-M553.
25. Morris JN, Fries BE, Mehr DR, et al. The MDS Cognitive Performance Scale. J Gerontol. 1994;49:174-182.
26. Burrows AB, Morris JN, Simon SE, Hirdes JP, Phillips CH: Development of a minimum data set-based depression rating scale for use in nursing homes. Age Ageing. 2000;29:165-172.
27. Zhang J, Yu F. What's the relative risk? a method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690-1691.
28. British National Formulary. 47th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2004.
29. Sérlyfjaskrá 2002-2003 (Icelandic National Formulary). Lyfjastofnun 2003. Available at: http: //www.serlyfjaskra.is. Accessed October 30, 2004.
30. Pharmindex Brevíř (Czech National Formulary). Prague, Czech Republic: Medimedia Information; November 2003.
31. Icelandic Medicines Control Agency Web site. Available at http://www.lyfjastofnun.is. Accessed June 1, 2004.
32. The Norwegian Pharmaceutical Products Compendium. Norwegian Medicine Agency. Available at: http://www.felleskatalogen.com. Accessed June 1, 2004.
33. Finnish Medical Network. Available at: http: //www.fimnet.fi/fennomed. Accessed July 1, 2004.
34. Italian Ministry of Health. Available at: http: //www.ministerosalute.it/ medicinali/bancadati /presentazione.jsp. Accessed June 15, 2004.
35. Danish Medicines Agency. Available at: http: //www.dkma.dk. Accessed June 1, 2004.
36. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001; 285:421-429.
37. McNutt LA, Coles FB, McAuliffe T, et al. Impact of regulation on benzodiazepine prescribing to a low income elderly population, New York State. J Clin Epidemiol. 1994;47:613-625.
38. Web site of the State Institute for Drug Control, Prague, the Czech Republic. Available at: http://www .sukl.cz. Accessed September 9, 2004.
39. Onder G, Landi F, Liperoti R, Fialová D, Gambassi G, Bernabei R. Impact of inappropriate drug use among hospitalized older adults. Bur J Clin Pharm. In press.
40. Linjakumpu T, Hartikainen S, Klaukka T, Koponen H, Kivelä S-L, Isoaho R. Psychotropics among the home-dwelling elderly: increasing trends. Int J Geriatr Psychiatry. 2002;17:874-883.
41. Thirstrup S, Kampmann JP. Adjustment of Europe's drug regulation to public health needs. Lancet. 2001;358:1734.
42. Adams SR, ed. Unnecessary drugs in the elderly including the psychotropic utilization protocol: a guidebook to OBRA implementation. Interpretive HCFA/OBRA Guidelines 483.25 (I). Rev ed. MED-PASS. Lancaster, England: AstraZeneca Pharmaceuticals; 2002.
43. Tamblyn R, Huang A, Perreault R, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ. 2003;169:549-556.
44. Chutka DS, Takahashi PY, Hoel RW. Inappropriate medications for elderly patients. Mayo Clin Proc. 2004;79:122-139.
45. Stewart RB, Cooper JW. Polypharmacy in the aged: practical solutions. Drugs Aging. 1994;4:449-461.
46. Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med. 2005; 165:68-74.